Table of Content

1 PDE Inhibitors Market Overview
1.1 PDE Inhibitors Product Overview
1.2 PDE Inhibitors Market Segment by Type
1.2.1 PDE5
1.2.2 PDE4
1.2.3 Viagra
1.2.4 Cialis
1.2.5 Levitra
1.2.6 Others
1.3 Global PDE Inhibitors Market Size by Type
1.3.1 Global PDE Inhibitors Market Size Overview by Type (2018-2034)
1.3.2 Global PDE Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global PDE Inhibitors Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PDE Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe PDE Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific PDE Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America PDE Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa PDE Inhibitors Sales Breakdown by Type (2018-2024)
2 Global PDE Inhibitors Market Competition by Company
2.1 Global Top Players by PDE Inhibitors Sales (2018-2024)
2.2 Global Top Players by PDE Inhibitors Revenue (2018-2024)
2.3 Global Top Players by PDE Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers PDE Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 PDE Inhibitors Market Competitive Situation and Trends
2.5.1 PDE Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PDE Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PDE Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into PDE Inhibitors Market
2.8 Key Manufacturers PDE Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PDE Inhibitors Status and Outlook by Region
3.1 Global PDE Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global PDE Inhibitors Historic Market Size by Region
3.2.1 Global PDE Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global PDE Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global PDE Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global PDE Inhibitors Forecasted Market Size by Region
3.3.1 Global PDE Inhibitors Sales in Volume by Region (2024-2034)
3.3.2 Global PDE Inhibitors Sales in Value by Region (2024-2034)
3.3.3 Global PDE Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global PDE Inhibitors by Application
4.1 PDE Inhibitors Market Segment by Application
4.1.1 Genitourinary
4.1.2 Cardiovascular Diseases
4.1.3 Dermatological Disorders
4.1.4 Respiratory Diseases
4.1.5 Schizophrenia
4.1.6 Alzheimer’S Disease
4.1.7 Huntington’S Disease
4.1.8 Others
4.2 Global PDE Inhibitors Market Size by Application
4.2.1 Global PDE Inhibitors Market Size Overview by Application (2018-2034)
4.2.2 Global PDE Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global PDE Inhibitors Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PDE Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe PDE Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific PDE Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America PDE Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa PDE Inhibitors Sales Breakdown by Application (2018-2024)
5 North America PDE Inhibitors by Country
5.1 North America PDE Inhibitors Historic Market Size by Country
5.1.1 North America PDE Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America PDE Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America PDE Inhibitors Sales in Value by Country (2018-2024)
5.2 North America PDE Inhibitors Forecasted Market Size by Country
5.2.1 North America PDE Inhibitors Sales in Volume by Country (2024-2034)
5.2.2 North America PDE Inhibitors Sales in Value by Country (2024-2034)
6 Europe PDE Inhibitors by Country
6.1 Europe PDE Inhibitors Historic Market Size by Country
6.1.1 Europe PDE Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe PDE Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe PDE Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe PDE Inhibitors Forecasted Market Size by Country
6.2.1 Europe PDE Inhibitors Sales in Volume by Country (2024-2034)
6.2.2 Europe PDE Inhibitors Sales in Value by Country (2024-2034)
7 Asia-Pacific PDE Inhibitors by Region
7.1 Asia-Pacific PDE Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific PDE Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific PDE Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific PDE Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific PDE Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific PDE Inhibitors Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific PDE Inhibitors Sales in Value by Region (2024-2034)
8 Latin America PDE Inhibitors by Country
8.1 Latin America PDE Inhibitors Historic Market Size by Country
8.1.1 Latin America PDE Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America PDE Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America PDE Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America PDE Inhibitors Forecasted Market Size by Country
8.2.1 Latin America PDE Inhibitors Sales in Volume by Country (2024-2034)
8.2.2 Latin America PDE Inhibitors Sales in Value by Country (2024-2034)
9 Middle East and Africa PDE Inhibitors by Country
9.1 Middle East and Africa PDE Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa PDE Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa PDE Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa PDE Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa PDE Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa PDE Inhibitors Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa PDE Inhibitors Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Hanmi Science Holding
10.1.1 Hanmi Science Holding Company Information
10.1.2 Hanmi Science Holding Introduction and Business Overview
10.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Hanmi Science Holding PDE Inhibitors Products Offered
10.1.5 Hanmi Science Holding Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim PDE Inhibitors Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Takeda Pharmaceuticals
10.3.1 Takeda Pharmaceuticals Company Information
10.3.2 Takeda Pharmaceuticals Introduction and Business Overview
10.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Takeda Pharmaceuticals PDE Inhibitors Products Offered
10.3.5 Takeda Pharmaceuticals Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AstraZeneca PDE Inhibitors Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bayer PDE Inhibitors Products Offered
10.5.5 Bayer Recent Development
10.6 Celgene
10.6.1 Celgene Company Information
10.6.2 Celgene Introduction and Business Overview
10.6.3 Celgene PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Celgene PDE Inhibitors Products Offered
10.6.5 Celgene Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Company Information
10.7.2 Eli Lilly Introduction and Business Overview
10.7.3 Eli Lilly PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Eli Lilly PDE Inhibitors Products Offered
10.7.5 Eli Lilly Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer PDE Inhibitors Products Offered
10.8.5 Pfizer Recent Development
10.9 BioCrea
10.9.1 BioCrea Company Information
10.9.2 BioCrea Introduction and Business Overview
10.9.3 BioCrea PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 BioCrea PDE Inhibitors Products Offered
10.9.5 BioCrea Recent Development
10.10 Dart NeuroScience
10.10.1 Dart NeuroScience Company Information
10.10.2 Dart NeuroScience Introduction and Business Overview
10.10.3 Dart NeuroScience PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Dart NeuroScience PDE Inhibitors Products Offered
10.10.5 Dart NeuroScience Recent Development
10.11 Carinopharm
10.11.1 Carinopharm Company Information
10.11.2 Carinopharm Introduction and Business Overview
10.11.3 Carinopharm PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Carinopharm PDE Inhibitors Products Offered
10.11.5 Carinopharm Recent Development
10.12 CTC Bio
10.12.1 CTC Bio Company Information
10.12.2 CTC Bio Introduction and Business Overview
10.12.3 CTC Bio PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.12.4 CTC Bio PDE Inhibitors Products Offered
10.12.5 CTC Bio Recent Development
10.13 FORUM Pharmaceuticals
10.13.1 FORUM Pharmaceuticals Company Information
10.13.2 FORUM Pharmaceuticals Introduction and Business Overview
10.13.3 FORUM Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.13.4 FORUM Pharmaceuticals PDE Inhibitors Products Offered
10.13.5 FORUM Pharmaceuticals Recent Development
10.14 Intra-Cellular Therapies
10.14.1 Intra-Cellular Therapies Company Information
10.14.2 Intra-Cellular Therapies Introduction and Business Overview
10.14.3 Intra-Cellular Therapies PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Intra-Cellular Therapies PDE Inhibitors Products Offered
10.14.5 Intra-Cellular Therapies Recent Development
10.15 Omeros Corporation
10.15.1 Omeros Corporation Company Information
10.15.2 Omeros Corporation Introduction and Business Overview
10.15.3 Omeros Corporation PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Omeros Corporation PDE Inhibitors Products Offered
10.15.5 Omeros Corporation Recent Development
10.16 Medimetriks Pharmaceuticals
10.16.1 Medimetriks Pharmaceuticals Company Information
10.16.2 Medimetriks Pharmaceuticals Introduction and Business Overview
10.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Products Offered
10.16.5 Medimetriks Pharmaceuticals Recent Development
10.17 NuSirt Biopharma
10.17.1 NuSirt Biopharma Company Information
10.17.2 NuSirt Biopharma Introduction and Business Overview
10.17.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.17.4 NuSirt Biopharma PDE Inhibitors Products Offered
10.17.5 NuSirt Biopharma Recent Development
10.18 Palobiopharma
10.18.1 Palobiopharma Company Information
10.18.2 Palobiopharma Introduction and Business Overview
10.18.3 Palobiopharma PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Palobiopharma PDE Inhibitors Products Offered
10.18.5 Palobiopharma Recent Development
10.19 Roivant Sciences
10.19.1 Roivant Sciences Company Information
10.19.2 Roivant Sciences Introduction and Business Overview
10.19.3 Roivant Sciences PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Roivant Sciences PDE Inhibitors Products Offered
10.19.5 Roivant Sciences Recent Development
10.20 Sagene Pharmaceuticals
10.20.1 Sagene Pharmaceuticals Company Information
10.20.2 Sagene Pharmaceuticals Introduction and Business Overview
10.20.3 Sagene Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Sagene Pharmaceuticals PDE Inhibitors Products Offered
10.20.5 Sagene Pharmaceuticals Recent Development
10.21 Tetra Discovery Partners
10.21.1 Tetra Discovery Partners Company Information
10.21.2 Tetra Discovery Partners Introduction and Business Overview
10.21.3 Tetra Discovery Partners PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Tetra Discovery Partners PDE Inhibitors Products Offered
10.21.5 Tetra Discovery Partners Recent Development
10.22 Tritech Biopharm
10.22.1 Tritech Biopharm Company Information
10.22.2 Tritech Biopharm Introduction and Business Overview
10.22.3 Tritech Biopharm PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Tritech Biopharm PDE Inhibitors Products Offered
10.22.5 Tritech Biopharm Recent Development
10.23 Otsuka
10.23.1 Otsuka Company Information
10.23.2 Otsuka Introduction and Business Overview
10.23.3 Otsuka PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Otsuka PDE Inhibitors Products Offered
10.23.5 Otsuka Recent Development
10.24 Chiesi Farmaceutici
10.24.1 Chiesi Farmaceutici Company Information
10.24.2 Chiesi Farmaceutici Introduction and Business Overview
10.24.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Chiesi Farmaceutici PDE Inhibitors Products Offered
10.24.5 Chiesi Farmaceutici Recent Development
10.25 Verona Pharma
10.25.1 Verona Pharma Company Information
10.25.2 Verona Pharma Introduction and Business Overview
10.25.3 Verona Pharma PDE Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Verona Pharma PDE Inhibitors Products Offered
10.25.5 Verona Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PDE Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PDE Inhibitors Industrial Chain Analysis
11.4 PDE Inhibitors Market Dynamics
11.4.1 PDE Inhibitors Industry Trends
11.4.2 PDE Inhibitors Market Drivers
11.4.3 PDE Inhibitors Market Challenges
11.4.4 PDE Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PDE Inhibitors Distributors
12.3 PDE Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of PDE5
Table 2. Major Company of PDE4
Table 3. Major Company of Viagra
Table 4. Major Company of Cialis
Table 5. Major Company of Levitra
Table 6. Major Company of Others
Table 7. Global PDE Inhibitors Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global PDE Inhibitors Sales by Type (2018-2024) & (K Units)
Table 9. Global PDE Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 10. Global PDE Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 11. Global PDE Inhibitors Market Share in Value by Type (2018-2024)
Table 12. Global PDE Inhibitors Price by Type (2018-2024) & (USD/Unit)
Table 13. Global PDE Inhibitors Sales by Type (2024-2034) & (K Units)
Table 14. Global PDE Inhibitors Sales Market Share in Volume by Type (2024-2034)
Table 15. Global PDE Inhibitors Sales by Type (2024-2034) & (US$ Million)
Table 16. Global PDE Inhibitors Sales Market Share in Value by Type (2024-2034)
Table 17. Global PDE Inhibitors Price by Type (2024-2034) & (USD/Unit)
Table 18. North America PDE Inhibitors Sales by Type (2018-2024) & (K Units)
Table 19. North America PDE Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe PDE Inhibitors Sales (K Units) by Type (2018-2024)
Table 21. Europe PDE Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific PDE Inhibitors Sales (K Units) by Type (2018-2024)
Table 23. Asia-Pacific PDE Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America PDE Inhibitors Sales (K Units) by Type (2018-2024)
Table 25. Latin America PDE Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa PDE Inhibitors Sales (K Units) by Type (2018-2024)
Table 27. Middle East and Africa PDE Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 28. Global PDE Inhibitors Sales by Company (2018-2024) & (K Units)
Table 29. Global PDE Inhibitors Sales Share by Company (2018-2024)
Table 30. Global PDE Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global PDE Inhibitors Revenue Share by Company (2018-2024)
Table 32. Global Market PDE Inhibitors Price by Company (2018-2024) & (USD/Unit)
Table 33. Global PDE Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global PDE Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PDE Inhibitors as of 2022)
Table 36. Date of Key Manufacturers Enter into PDE Inhibitors Market
Table 37. Key Manufacturers PDE Inhibitors Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global PDE Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global PDE Inhibitors Sales by Region (2018-2024) & (K Units)
Table 41. Global PDE Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 42. Global PDE Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 43. Global PDE Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 44. Global PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 45. Global PDE Inhibitors Sales by Region (2024-2034) & (K Units)
Table 46. Global PDE Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 47. Global PDE Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 48. Global PDE Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 49. Global PDE Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 50. Global PDE Inhibitors Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global PDE Inhibitors Sales by Application (2018-2024) & (K Units)
Table 52. Global PDE Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 53. Global PDE Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 54. Global PDE Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 55. Global PDE Inhibitors Price by Application (2018-2024) & (USD/Unit)
Table 56. Global PDE Inhibitors Sales by Application (2024-2034) & (K Units)
Table 57. Global PDE Inhibitors Sales Market Share in Volume by Application (2024-2034)
Table 58. Global PDE Inhibitors Sales by Application (2024-2034) & (US$ Million)
Table 59. Global PDE Inhibitors Sales Market Share in Value by Application (2024-2034)
Table 60. Global PDE Inhibitors Price by Application (2024-2034) & (USD/Unit)
Table 61. North America PDE Inhibitors Sales by Application (2018-2024) (K Units)
Table 62. North America PDE Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe PDE Inhibitors Sales by Application (2018-2024) (K Units)
Table 64. Europe PDE Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific PDE Inhibitors Sales by Application (2018-2024) (K Units)
Table 66. Asia-Pacific PDE Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America PDE Inhibitors Sales by Application (2018-2024) (K Units)
Table 68. Latin America PDE Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa PDE Inhibitors Sales by Application (2018-2024) (K Units)
Table 70. Middle East and Africa PDE Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 71. North America PDE Inhibitors Sales by Country (2018-2024) & (K Units)
Table 72. North America PDE Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 73. North America PDE Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 74. North America PDE Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 75. North America PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 76. North America PDE Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 77. North America PDE Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 78. North America PDE Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 79. Europe PDE Inhibitors Sales by Country (2018-2024) & (K Units)
Table 80. Europe PDE Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe PDE Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe PDE Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 83. Europe PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 84. Europe PDE Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe PDE Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe PDE Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific PDE Inhibitors Sales by Region (2018-2024) & (K Units)
Table 88. Asia-Pacific PDE Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific PDE Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific PDE Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific PDE Inhibitors Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific PDE Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific PDE Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific PDE Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America PDE Inhibitors Sales by Country (2018-2024) & (K Units)
Table 96. Latin America PDE Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America PDE Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America PDE Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 100. Latin America PDE Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America PDE Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America PDE Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa PDE Inhibitors Sales by Country (2018-2024) & (K Units)
Table 104. Middle East and Africa PDE Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa PDE Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa PDE Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa PDE Inhibitors Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa PDE Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa PDE Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa PDE Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 111. Hanmi Science Holding Company Information
Table 112. Hanmi Science Holding Introduction and Business Overview
Table 113. Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 114. Hanmi Science Holding PDE Inhibitors Product
Table 115. Hanmi Science Holding Recent Development
Table 116. Boehringer Ingelheim Company Information
Table 117. Boehringer Ingelheim Introduction and Business Overview
Table 118. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 119. Boehringer Ingelheim PDE Inhibitors Product
Table 120. Boehringer Ingelheim Recent Development
Table 121. Takeda Pharmaceuticals Company Information
Table 122. Takeda Pharmaceuticals Introduction and Business Overview
Table 123. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 124. Takeda Pharmaceuticals PDE Inhibitors Product
Table 125. Takeda Pharmaceuticals Recent Development
Table 126. AstraZeneca Company Information
Table 127. AstraZeneca Introduction and Business Overview
Table 128. AstraZeneca PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 129. AstraZeneca PDE Inhibitors Product
Table 130. AstraZeneca Recent Development
Table 131. Bayer Company Information
Table 132. Bayer Introduction and Business Overview
Table 133. Bayer PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 134. Bayer PDE Inhibitors Product
Table 135. Bayer Recent Development
Table 136. Celgene Company Information
Table 137. Celgene Introduction and Business Overview
Table 138. Celgene PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 139. Celgene PDE Inhibitors Product
Table 140. Celgene Recent Development
Table 141. Eli Lilly Company Information
Table 142. Eli Lilly Introduction and Business Overview
Table 143. Eli Lilly PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 144. Eli Lilly PDE Inhibitors Product
Table 145. Eli Lilly Recent Development
Table 146. Pfizer Company Information
Table 147. Pfizer Introduction and Business Overview
Table 148. Pfizer PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 149. Pfizer PDE Inhibitors Product
Table 150. Pfizer Recent Development
Table 151. BioCrea Company Information
Table 152. BioCrea Introduction and Business Overview
Table 153. BioCrea PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 154. BioCrea PDE Inhibitors Product
Table 155. BioCrea Recent Development
Table 156. Dart NeuroScience Company Information
Table 157. Dart NeuroScience Introduction and Business Overview
Table 158. Dart NeuroScience PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 159. Dart NeuroScience PDE Inhibitors Product
Table 160. Dart NeuroScience Recent Development
Table 161. Carinopharm Company Information
Table 162. Carinopharm Introduction and Business Overview
Table 163. Carinopharm PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 164. Carinopharm PDE Inhibitors Product
Table 165. Carinopharm Recent Development
Table 166. CTC Bio Company Information
Table 167. CTC Bio Introduction and Business Overview
Table 168. CTC Bio PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 169. CTC Bio PDE Inhibitors Product
Table 170. CTC Bio Recent Development
Table 171. FORUM Pharmaceuticals Company Information
Table 172. FORUM Pharmaceuticals Introduction and Business Overview
Table 173. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 174. FORUM Pharmaceuticals PDE Inhibitors Product
Table 175. FORUM Pharmaceuticals Recent Development
Table 176. Intra-Cellular Therapies Company Information
Table 177. Intra-Cellular Therapies Introduction and Business Overview
Table 178. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 179. Intra-Cellular Therapies PDE Inhibitors Product
Table 180. Intra-Cellular Therapies Recent Development
Table 181. Omeros Corporation Company Information
Table 182. Omeros Corporation Introduction and Business Overview
Table 183. Omeros Corporation PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 184. Omeros Corporation PDE Inhibitors Product
Table 185. Omeros Corporation Recent Development
Table 186. Medimetriks Pharmaceuticals Company Information
Table 187. Medimetriks Pharmaceuticals Introduction and Business Overview
Table 188. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 189. Medimetriks Pharmaceuticals PDE Inhibitors Product
Table 190. Medimetriks Pharmaceuticals Recent Development
Table 191. NuSirt Biopharma Company Information
Table 192. NuSirt Biopharma Introduction and Business Overview
Table 193. NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 194. NuSirt Biopharma PDE Inhibitors Product
Table 195. NuSirt Biopharma Recent Development
Table 196. Palobiopharma Company Information
Table 197. Palobiopharma Introduction and Business Overview
Table 198. Palobiopharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 199. Palobiopharma PDE Inhibitors Product
Table 200. Palobiopharma Recent Development
Table 201. Roivant Sciences Company Information
Table 202. Roivant Sciences Introduction and Business Overview
Table 203. Roivant Sciences PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 204. Roivant Sciences PDE Inhibitors Product
Table 205. Roivant Sciences Recent Development
Table 206. Sagene Pharmaceuticals Company Information
Table 207. Sagene Pharmaceuticals Introduction and Business Overview
Table 208. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 209. Sagene Pharmaceuticals PDE Inhibitors Product
Table 210. Sagene Pharmaceuticals Recent Development
Table 211. Tetra Discovery Partners Company Information
Table 212. Tetra Discovery Partners Introduction and Business Overview
Table 213. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 214. Tetra Discovery Partners PDE Inhibitors Product
Table 215. Tetra Discovery Partners Recent Development
Table 216. Tritech Biopharm Company Information
Table 217. Tritech Biopharm Introduction and Business Overview
Table 218. Tritech Biopharm PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 219. Tritech Biopharm PDE Inhibitors Product
Table 220. Tritech Biopharm Recent Development
Table 221. Otsuka Company Information
Table 222. Otsuka Introduction and Business Overview
Table 223. Otsuka PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 224. Otsuka PDE Inhibitors Product
Table 225. Otsuka Recent Development
Table 226. Chiesi Farmaceutici Company Information
Table 227. Chiesi Farmaceutici Introduction and Business Overview
Table 228. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 229. Chiesi Farmaceutici PDE Inhibitors Product
Table 230. Chiesi Farmaceutici Recent Development
Table 231. Verona Pharma Introduction and Business Overview
Table 232. Verona Pharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 233. Verona Pharma PDE Inhibitors Product
Table 234. Verona Pharma Recent Development
Table 235. Verona Pharma Company Information
Table 236. Key Raw Materials Lists
Table 237. Raw Materials Key Suppliers Lists
Table 238. PDE Inhibitors Market Trends
Table 239. PDE Inhibitors Market Drivers
Table 240. PDE Inhibitors Market Challenges
Table 241. PDE Inhibitors Market Restraints
Table 242. PDE Inhibitors Distributors List
Table 243. PDE Inhibitors Downstream Customers
Table 244. Research Programs/Design for This Report
Table 245. Key Data Information from Secondary Sources
Table 246. Key Data Information from Primary Sources
List of Figures
Figure 1. PDE Inhibitors Product Picture
Figure 2. Global PDE Inhibitors Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PDE Inhibitors Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global PDE Inhibitors Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of PDE5
Figure 6. Global PDE5 Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of PDE4
Figure 8. Global PDE4 Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Viagra
Figure 10. Global Viagra Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Cialis
Figure 12. Global Cialis Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Levitra
Figure 14. Global Levitra Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Global PDE Inhibitors Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global PDE Inhibitors Sales Market Share by Type in 2022 & 2034
Figure 19. North America PDE Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. North America PDE Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Europe PDE Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Europe PDE Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific PDE Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific PDE Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. Latin America PDE Inhibitors Sales Market Share in Volume by Type in 2022
Figure 26. Latin America PDE Inhibitors Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa PDE Inhibitors Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa PDE Inhibitors Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by PDE Inhibitors Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by PDE Inhibitors Revenue in 2022
Figure 31. PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Genitourinary
Figure 33. Global Genitourinary Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Cardiovascular Diseases
Figure 35. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Dermatological Disorders
Figure 37. Global Dermatological Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Respiratory Diseases
Figure 39. Global Respiratory Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Schizophrenia
Figure 41. Global Schizophrenia Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Product Picture of Alzheimer’S Disease
Figure 43. Global Alzheimer’S Disease Sales YoY Growth (2018-2034) & (K Units)
Figure 44. Product Picture of Huntington’S Disease
Figure 45. Global Huntington’S Disease Sales YoY Growth (2018-2034) & (K Units)
Figure 46. Product Picture of Others
Figure 47. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 48. Global PDE Inhibitors Sales by Application (2018-2034) & (US$ Million)
Figure 49. Global PDE Inhibitors Sales Market Share by Application in 2022 & 2034
Figure 50. North America PDE Inhibitors Sales Market Share in Volume by Application in 2022
Figure 51. North America PDE Inhibitors Sales Market Share in Value by Application in 2022
Figure 52. Europe PDE Inhibitors Sales Market Share in Volume by Application in 2022
Figure 53. Europe PDE Inhibitors Sales Market Share in Value by Application in 2022
Figure 54. Asia-Pacific PDE Inhibitors Sales Market Share in Volume by Application in 2022
Figure 55. Asia-Pacific PDE Inhibitors Sales Market Share in Value by Application in 2022
Figure 56. Latin America PDE Inhibitors Sales Market Share in Volume by Application in 2022
Figure 57. Latin America PDE Inhibitors Sales Market Share in Value by Application in 2022
Figure 58. Middle East and Africa PDE Inhibitors Sales Market Share in Value by Application in 2022
Figure 59. Key Raw Materials Price
Figure 60. PDE Inhibitors Manufacturing Cost Structure
Figure 61. PDE Inhibitors Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed